ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04064	NF-kappa B signaling pathway	20/202	96/7206	1.1721021969e-12
ko04650	Natural killer cell mediated cytotoxicity	20/202	97/7206	1.44073536056e-12
ko04380	Osteoclast differentiation	23/202	134/7206	1.64385701946e-12
ko04060	Cytokine-cytokine receptor interaction	26/202	191/7206	1.34844903772e-11
ko05340	Primary immunodeficiency	11/202	30/7206	2.19491196185e-10
ko04621	NOD-like receptor signaling pathway	22/202	157/7206	3.20351748532e-10
ko04660	T cell receptor signaling pathway	19/202	124/7206	1.18781137129e-09
ko05140	Leishmaniasis	15/202	75/7206	1.60000041126e-09
ko05152	Tuberculosis	23/202	187/7206	1.73537228152e-09
ko05162	Measles	18/202	120/7206	4.71682050742e-09
ko05168	Herpes simplex infection	22/202	182/7206	5.58431033789e-09
ko05330	Allograft rejection	9/202	24/7206	8.12849611867e-09
ko04620	Toll-like receptor signaling pathway	16/202	100/7206	1.35917672407e-08
ko04662	B cell receptor signaling pathway	15/202	88/7206	1.61478045974e-08
ko05150	Staphylococcus aureus infection	10/202	36/7206	3.22979166701e-08
ko05164	Influenza A	19/202	167/7206	1.73639170479e-07
ko05144	Malaria	10/202	45/7206	3.25185571003e-07
ko05145	Toxoplasmosis	16/202	126/7206	3.79066194086e-07
ko04630	Jak-STAT signaling pathway	16/202	132/7206	7.21089664136e-07
ko05320	Autoimmune thyroid disease	8/202	29/7206	8.58883229353e-07
ko04622	RIG-I-like receptor signaling pathway	11/202	62/7206	9.29918055709e-07
ko05161	Hepatitis B	18/202	173/7206	1.41112502284e-06
ko05321	Inflammatory bowel disease (IBD)	10/202	56/7206	2.77337593833e-06
ko05332	Graft-versus-host disease	6/202	18/7206	6.31236700033e-06
ko04659	Th17 cell differentiation	13/202	106/7206	7.20583878112e-06
ko04664	Fc epsilon RI signaling pathway	11/202	77/7206	8.46026467451e-06
ko05142	Chagas disease (American trypanosomiasis)	14/202	130/7206	1.47110180495e-05
ko04940	Type I diabetes mellitus	7/202	32/7206	2.27385925715e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/202	191/7206	2.28971487553e-05
ko05133	Pertussis	11/202	87/7206	2.77522461489e-05
ko04668	TNF signaling pathway	13/202	120/7206	2.80884913952e-05
ko04666	Fc gamma R-mediated phagocytosis	13/202	122/7206	3.35295849198e-05
ko04217	Necroptosis	16/202	178/7206	3.55662943203e-05
ko04210	Apoptosis	16/202	180/7206	4.07994668686e-05
ko04672	Intestinal immune network for IgA production	7/202	37/7206	6.174995967e-05
ko05310	Asthma	5/202	17/7206	7.74399891453e-05
ko04623	Cytosolic DNA-sensing pathway	7/202	41/7206	0.000122614689379
ko04612	Antigen processing and presentation	9/202	77/7206	0.00027696094018
ko04658	Th1 and Th2 cell differentiation	10/202	96/7206	0.000331397821568
ko05169	Epstein-Barr virus infection	15/202	206/7206	0.000638750479283
ko04610	Complement and coagulation cascades	8/202	79/7206	0.00157204045069
ko05143	African trypanosomiasis	5/202	32/7206	0.00179006997092
ko04145	Phagosome	12/202	162/7206	0.00191471431855
ko05131	Shigellosis	8/202	82/7206	0.00199948233869
ko04611	Platelet activation	12/202	163/7206	0.00201701641027
ko05160	Hepatitis C	11/202	153/7206	0.00369453081636
ko04062	Chemokine signaling pathway	13/202	201/7206	0.00414401093135
ko05166	HTLV-I infection	17/202	292/7206	0.00536036275077
ko04640	Hematopoietic cell lineage	6/202	64/7206	0.00874604840213
ko04670	Leukocyte transendothelial migration	10/202	151/7206	0.00973875879821
ko05323	Rheumatoid arthritis	7/202	89/7206	0.0121425029512
ko05134	Legionellosis	6/202	74/7206	0.0171834909209
ko05416	Viral myocarditis	5/202	55/7206	0.0184247928606
ko05146	Amoebiasis	7/202	99/7206	0.0207930265985
ko05020	Prion diseases	4/202	40/7206	0.0249244441474
ko05016	Huntington's disease	1/202	215/7206	0.0323999590099
ko04657	IL-17 signaling pathway	6/202	87/7206	0.0348421158139
ko00511	Other glycan degradation	3/202	26/7206	0.0351272054034
ko04020	Calcium signaling pathway	2/202	265/7206	0.0352192107085
ko04142	Lysosome	9/202	151/7206	0.0388107384298
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/202	28/7206	0.0425034865946